Detalhe da pesquisa
1.
A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine.
Br J Cancer
; 120(6): 579-586, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30783204
2.
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
Br J Cancer
; 120(4): 379-386, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679780
3.
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Lancet
; 391(10126): 1163-1173, 2018 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29433850
4.
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma.
BMC Cancer
; 16(1): 779, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27724887
5.
Plasma N-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome.
Future Oncol
; 11(2): 193-203, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25040106
6.
Targeting mTOR dependency in pancreatic cancer.
Gut
; 63(9): 1481-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24717934
7.
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Eur J Cancer
; 202: 114009, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547774
8.
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
Proc Natl Acad Sci U S A
; 107(1): 246-51, 2010 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20018721
9.
LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest.
Gastroenterology
; 139(2): 586-97, 597.e1-6, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20452353
10.
Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma.
Gastroenterology
; 139(1): 292-303, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20303350
11.
Serum beta-HCG and CA-125 as tumor markers in a patient with osteosarcoma: case report.
Tumori
; 97(1): 109-14, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21528673
12.
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study.
Breast Cancer Res Treat
; 122(3): 787-94, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20559708
13.
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.
J Immunother Cancer
; 8(1)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317292
14.
Antiproliferative effect of exemestane in lung cancer cells.
Mol Cancer
; 8: 109, 2009 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19930708
15.
Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.
Anticancer Res
; 29(6): 2159-66, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19528476
16.
A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors.
Clin Cancer Res
; 14(3): 804-10, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245542
17.
Coexistent malignant melanoma and renal cell carcinoma.
Tumori
; 95(4): 518-20, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19856667
18.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Eur J Cancer
; 120: 132-139, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522033
19.
A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.
Cancer Chemother Pharmacol
; 61(3): 435-41, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17440725
20.
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).
J Clin Oncol
; 36(12): 1232-1239, 2018 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528792